Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04232189 · ClinicalTrials.gov registry record
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
A clinical trial, sponsored by Gynuity Health Projects.
- Terminated
- Registry status
- 275
- Enrollment target
NCT04232189: Clinical Trial study, sponsored by Gynuity Health Projects.
NCT04232189 is a clinical trial that was terminated before completion, run by Gynuity Health Projects. The registered enrollment target is 275 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04232189 was terminated before completion, sponsored by Gynuity Health Projects.
- TERMINATED
- Registry status
- 275 participants
- Enrollment target
Study Summary
This will be a case-series multicenter study enrolling 800 pregnant people. Serum will be collected from people seeking abortion and assayed at a qualified laboratory.
Primary Outcome
Negative Predictive Value of Prespecified Protein Concentration in Serum for Predicting a GA of ≤70 days is \>95%
Interventions
- OTHER no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2019-11-12 |
| Est. Completion | 2020-04-14 |
Why NCT04232189 stopped before completion
NCT04232189 is an observational study that tracks outcomes without assigning an intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which no intervention is the first listed.
NCT04232189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04232189 about?
NCT04232189 is a clinical study titled "Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion". This will be a case-series multicenter study enrolling 800 pregnant people. Serum will be collected from people seeking abortion and assayed at a qualified laboratory.
What is the current status of trial NCT04232189?
This trial is currently terminated. The enrollment target is 275 participants. The study started on 2019-11-12. Estimated completion is 2020-04-14.
What interventions are being tested in trial NCT04232189?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT04232189?
This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI